Amitiza and Enulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amitiza (lubiprostone) and Enulose (lactulose). Common drug interactions include bronchitis chronic among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Amitiza and Enulose. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

What is Enulose?

Enulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 711 Enulose users. Check the latest studies of Enulose.



On Jul, 16, 2026

13 people who take Amitiza and Enulose together, and have interactions are studied.

Amitiza and Enulose drug interactions.

What are the common drug interactions of Amitiza and Enulose, by gender? *:

female:

  1. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  2. Carotid artery stenosis (narrowing of carotid artery)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Foot fracture
  5. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Lung disorder (lung disease)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  10. Memory impairment

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)

What are the common drug interactions of Amitiza and Enulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Ataxia (loss of full control of bodily movements)
  5. Back pain
  6. Candidiasis (candidiasis or thrush is a fungal infection)
  7. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)
  8. Colitis (inflammation of colon)
  9. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  10. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Abdominal pain
  2. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  3. Carotid artery stenosis (narrowing of carotid artery)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Dyspnoea (difficult or laboured respiration)
  6. Foot fracture
  7. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  8. Headache (pain in head)
  9. Lung disorder (lung disease)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  3. Heart rate increased
  4. Muscle rupture (tear in muscle)
  5. Urinary tract infection bacterial
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Angina pectoris (chest pain due to ischemia of the heart muscle)
  9. Blood pressure increased
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 6 people, 46.15%
  2. Nausea And Vomiting: 6 people, 46.15%
  3. Pain: 6 people, 46.15%
  4. Neuralgia (pain in one or more nerves): 4 people, 30.77%
  5. High Blood Cholesterol: 4 people, 30.77%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 30.77%
  7. Insomnia (sleeplessness): 4 people, 30.77%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 30.77%
  9. Stress And Anxiety: 4 people, 30.77%
  10. Depression: 4 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take Amitiza and Enulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amitiza and Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amitiza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lubiprostone and lactulose (the active ingredients of Amitiza and Enulose, respectively), and Amitiza and Enulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: